Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice
Open Access
- 4 April 2013
- journal article
- Published by Springer Nature in BMC Medicine
- Vol. 11 (1) , 92
Abstract
We investigated interactions between genetically and autoimmune-mediated coagulopathies by inducing experimental antiphospholipid syndrome (eAPS) in mice carrying the factor V Leiden (FVL) mutation.Keywords
This publication has 45 references indexed in Scilit:
- Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female backgroundNeurobiology of Aging, 2011
- Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: a meta-analysisGenes & Immunity, 2009
- Paraneoplastic syndromes of the CNSThe Lancet Neurology, 2008
- Identification of Histidine‐Rich Glycoprotein, a Potential Autoantigen, in Human and Rat Brain PreparationsAnnals of the New York Academy of Sciences, 2007
- Coagulation factor V and thrombophilia: Background and mechanismsThrombosis and Haemostasis, 2007
- Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndromeBehavioural Brain Research, 2006
- Acquired Activated Protein C Resistance Associated with IgG Antibodies against β2-Glycoprotein I and Prothrombin as a Strong Risk Factor for Venous ThromboembolismClinical Chemistry, 2005
- Epidemiology of Factor V Leiden: Clinical ImplicationsSeminars in Thrombosis and Hemostasis, 1998
- Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.Journal of Clinical Investigation, 1997
- Activated protein C resistance phenotype and genotype in patients with primary antiphospholipid syndromeBlood Coagulation & Fibrinolysis, 1996